Background Use of an interferon-γ (IFN-γ) release assay or tuberculin skin test for detection
and management of latent tuberculosis infection is controversial. For both types of test, we …

BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes
significant morbidity and mortality. The aim of these clinical standards is to provide guidance …

Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in
16 countries on 5 continents showed that attendance at tuberculosis centers was lower …

Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America …

BACKGROUND: Tuberculosis (TB) preventive therapy (TPT) decreases the risk of
developing TB disease and its associated morbidity and mortality. The aim of these clinical …

Tuberculosis (TB) still represents a major public health issue in spite of the significant impact
of the efforts made by the World Health Organization (WHO) and partners to improve its …

Multidrug-resistant (MDR) tuberculosis (TB), resistant to isoniazid and rifampicin, continues
to be one of the most important threats to controlling the TB epidemic. Over the last few …

We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …

The surface finishing techniques can be divided into two categories: traditional and
advanced. To overcome some of the problems of traditional finishing techniques, hybridized …

Tuberculosis is the leading cause of death globally that is due to a single pathogen, and up
to a fifth of patients with tuberculosis in high-incidence countries are children younger than …